Seed Train Intensification

Seed train intensification aims to generate ultra high-density cell cultures at optimal points during cell expansion using a robust cell retention device, such as the XCell ATF^® Device, prior to the inoculation of the production bioreactor.

Traditional Seed Train

The purpose of a seed train is the generation of an adequate number of cells for the inoculation of a production bioreactor.  The cells are usually run through many cultivation systems which become larger with each passage (e.g. T-flasks, roller bottles or shake flasks, small scale bioreactor systems and subsequently larger bioreactors). The production bioreactor (N stage) is inoculated out of the largest seed train scale.

Challenges

3-4 weeks to production bioreactor
Multiple steps, some require open handling
Seed variability creates scheduling risk and/or output variablity

8 steps

42 days to product

28 days to N

14 days in N stage

intensified seed Train

Intensified seed trains perform process intensification, using a cell retention device such as the XCell ATF^® Device, at optimal points during cell expansion to attain the highest cell density inoculum for the production (N) bioreactor. Seed train intensification promotes flexibility and scalability, allowing small labs and global players alike to grow the exact amount of cell culture required, irrespective of whether they are needed for a clinical study, a new therapy or a personalized treatment.

Benefits

Less time in production reactor
More batches per year
Shorter seed train times
Reduced plant footprint
Increased flexibility
Reduced COGs

OPTION 1 | N-1 Intensification

Intensify cell growth in the step (N-1) prior to the production bioreactor (N). This process intensification is done by attaching a cell retention device to the N-1 bioreactor to attain high cell density and viability. This seeds the production bioreactor at a higher starting cell density and shortens the production bioreactor run time. This can dramatically increase the facility output without direct change to the core production process.

Variations are possible on this theme, depending on existing facility layouts, one common one being that one N-1 bioreactor might inoculate two production vessels.

8 steps

37 days to product

30 days to N

7 days in N stage

OPTION 2 | N-2 or earlier Intensification

Perform process intensification earlier in the workflow by attaching the XCell ATF^® Device to the N-2 or earlier bioreactors. This can save as much as 1 week in the seed train and reduce or eliminate several bioreactors later in the workflow. This means less bioreactors to purchase, operate, clean, and validate - saving clean room floor space while mitigating risk.

6 steps

31 days to product

24 days to N

7 days in N stage

OPTION 3 | Large Volume High Density (LVHD) Frozen Process Intermediaries

De-couple cell bank and variable early cell culture expansion from manufacturing by producing and freezing intermediate cells. This ensures cells of high cell concentration and viability, and known volume, are provided to manufacturing every time. This process intensification option can be performed in a central facility and distributed globally, making scheduling vastly easier with inoculation occurring “on demand”.

5 steps and time not relevant

(performed outside production timeline)

OPTION 4 | Frozen Process Intermediaries with N-1 Intensification

Combine Frozen Process Intermediaries and N-1 or earlier intensification. This enables Manufacturing on Demand, and a truly flexible facility ready for batch or continuous operation.

Significantly smaller footprint and less equipment
Reduced CAPEX for equipment and cleanroom
Fewer operational steps
More repeatable output
Faster turnaround of equipment and more batches per year

3 steps

13 days to product

6 days to N

7 days in N stage